Epitope-mapped monoclonal antibodies against the HPV16E1--E4 protein
- PMID: 1371027
- DOI: 10.1016/0042-6822(92)90327-l
Epitope-mapped monoclonal antibodies against the HPV16E1--E4 protein
Abstract
The human papillomavirus (HPV) E1--E4 protein is the only nonstructural late protein encoded by the virus. We have isolated three hybridomas producing monoclonal antibodies to the E1--E4 protein of HPV16, which is the HPV type most frequently associated with cervical cancer. The three antibodies (TVG 401, 402, and 403) detect adjacent epitopes within the major seroreactive region of the molecule and show no reactivity against the E4 proteins of HPV1, HPV2, HPV4, or HPV6. The E1--E4 protein migrates as a 10K species on SDS-gel electrophoresis and forms cytoplasmic inclusion granules in infected cells in vitro similar in appearance to those produced by HPV1 in benign warts. In naturally occurring HPV16-induced tumors the E1--E4 protein was detected in the cytoplasm of cells in the upper layers of the lesion in areas in which HPV16 DNA replication was occurring, as determined by in situ hybridization. Although the epitopes recognized by these monoclonal antibodies survive brief fixation in 5% formaldehyde, reactivity was destroyed by prolonged fixation. These monoclonal antibodies represent the first against HPV16 E1--E4 and should complement those already available to E7 and L1 for the screening of frozen sections of clinical biopsies and will be of value in monitoring the progression of HPV infection from benign lesions to invasive cancer.
Similar articles
-
Independent association of antibodies against human papillomavirus type 16 E1/E4 and E7 proteins with cervical cancer.Virology. 1992 Oct;190(2):724-32. doi: 10.1016/0042-6822(92)90910-h. Virology. 1992. PMID: 1325704
-
Characterization of events during the late stages of HPV16 infection in vivo using high-affinity synthetic Fabs to E4.Virology. 1997 Nov 10;238(1):40-52. doi: 10.1006/viro.1997.8768. Virology. 1997. PMID: 9375007
-
Association of the antibodies against human papillomavirus 16 E4 and E7 proteins with cervical cancer positive for human papillomavirus DNA.Int J Cancer. 1993 Jun 19;54(4):624-8. doi: 10.1002/ijc.2910540417. Int J Cancer. 1993. PMID: 8390409
-
Detection of antibodies to L1, L2, and E4 proteins of human papillomavirus types 6, 11, and 16 by ELISA using synthetic peptides.J Med Virol. 1995 Apr;45(4):410-4. doi: 10.1002/jmv.1890450410. J Med Virol. 1995. PMID: 7545211
-
Developments in L2-based human papillomavirus (HPV) vaccines.Virus Res. 2017 Mar 2;231:166-175. doi: 10.1016/j.virusres.2016.11.020. Epub 2016 Nov 23. Virus Res. 2017. PMID: 27889616 Free PMC article. Review.
Cited by
-
Human papillomavirus type 16 E1circumflexE4 contributes to multiple facets of the papillomavirus life cycle.J Virol. 2005 Oct;79(20):13150-65. doi: 10.1128/JVI.79.20.13150-13165.2005. J Virol. 2005. PMID: 16189016 Free PMC article.
-
Functional analysis of the human papillomavirus type 16 E1=E4 protein provides a mechanism for in vivo and in vitro keratin filament reorganization.J Virol. 2004 Jan;78(2):821-33. doi: 10.1128/jvi.78.2.821-833.2004. J Virol. 2004. PMID: 14694114 Free PMC article.
-
Human papillomavirus type 16 E1 E4-induced G2 arrest is associated with cytoplasmic retention of active Cdk1/cyclin B1 complexes.J Virol. 2005 Apr;79(7):3998-4011. doi: 10.1128/JVI.79.7.3998-4011.2005. J Virol. 2005. PMID: 15767402 Free PMC article.
-
Role of calpain in the formation of human papillomavirus type 16 E1^E4 amyloid fibers and reorganization of the keratin network.J Virol. 2011 Oct;85(19):9984-97. doi: 10.1128/JVI.02158-10. Epub 2011 Jul 13. J Virol. 2011. PMID: 21752901 Free PMC article.
-
Modulation of the cell division cycle by human papillomavirus type 18 E4.J Virol. 2002 Nov;76(21):10914-20. doi: 10.1128/jvi.76.21.10914-10920.2002. J Virol. 2002. PMID: 12368334 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases